News

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...
RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...
Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...
Researchers working on mRNA vaccines fear federal funding might be halted, with many looking to move projects abroad ...
Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...
Newton-Wellesley Hospital said five staff members who had worked on its fifth floor were diagnosed with brain tumors — none ...
A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.
For years, Robert F. Kennedy Jr. has raised questions about vaccine safety. Now, as the Secretary of Health and Human ...
In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks that Jim Cramer ...
In a report released today, Michael Yee from Jefferies maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of ...
The surprise delay is casting new uncertainty on the fate of another vaccine awaiting FDA action: Moderna’s next-generation Covid-19 shot, called mRNA-1283, which is set for a decision by May 31.